Effects of dietary perilla oil, soybean oil and safflower oil on 7,12-dimethylbenz[a]anthracene (DMBA) and 1,2-dimethyl-hydrazine (DMH)-induced mammary gland and colon carcinogenesis in female SD rats.
The effects of diet supplemented with perilla oil, which contains a large amount of n-3 alpha-linolenic acid, and n-6 linoleic acid rich soybean and safflower oil supplemented diets on 7,12-dimethylbenz[a]anthracene (DMBA)- and 1,2-dimethylhydrazine (DMH)-induced mammary gland and colon carcinogenesis were investigated in female SD rats. Groups of 23 or 24, 5 week old animals were first given three s.c. injections of 40 mg/kg body wt DMH followed by a single intragastric administration of 50 mg/kg body wt DMBA within 2 weeks of the commencement. Starting 1 week after the DMBA treatment, they were administered pellet diet containing 10% perilla oil, soybean oil or safflower oil for the succeeding 33 weeks. Histological examination revealed that the resultant numbers of mammary tumors per rat were significantly lower in rats given perilla oil diet (4.4 +/- 2.5) than in the soybean oil diet group (6.5 +/- 3.9). Furthermore, colon tumor incidence was significantly lower in animals receiving the perilla oil supplement (18.2%) than in those given safflower oil diet (47.4%), and the numbers of colon tumors per rat tended to be lowest in rats administered perilla oil. Also the incidence of nephroblastomas in rats receiving perilla oil diet (0%) was significantly lower than that for the soybean oil diet group (23.8%). The results thus indicate that the alpha-linolenic acid (n-3)-rich perilla oil diet inhibits development of mammary gland, colon and kidney tumors as compared to linoleic acid (n-6)-rich safflower or soybean oil diet.
Hirose
M
M
First Department of Pathology, Nagoya City University, Medical School, Japan.
Masuda
A
A
Ito
N
N
Kamano
K
K
Okuyama
H
H
D019813:1,2-Dimethylhydrazine; D015127:9,10-Dimethyl-1,2-benzanthracene; D000230:Adenocarcinoma / Q000139:chemically induced*; D000232:Adenofibroma / Q000139:chemically induced*; D000236:Adenoma / Q000139:chemically induced; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002273:Carcinogens; D002291:Carcinoma, Papillary / Q000139:chemically induced; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced; D003110:Colonic Neoplasms / Q000139:chemically induced*; D004042:Dietary Fats, Unsaturated / Q000494:pharmacology; D004127:Dimethylhydrazines; D004428:Ear Neoplasms / Q000139:chemically induced; D005260:Female; D008041:Linoleic Acids / Q000494:pharmacology*; D015674:Mammary Neoplasms, Animal / Q000139:chemically induced*; D008763:Methylhydrazines; D010212:Papilloma / Q000139:chemically induced; D010938:Plant Oils / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D012450:Safflower Oil / Q000494:pharmacology*; D012626:Sebaceous Gland Neoplasms / Q000139:chemically induced; D013024:Soybean Oil / Q000494:pharmacology*; D017962:alpha-Linolenic Acid
D002273:Carcinogens; D004042:Dietary Fats, Unsaturated; D004127:Dimethylhydrazines; D008041:Linoleic Acids; D008763:Methylhydrazines; D010938:Plant Oils; D017962:alpha-Linolenic Acid; D015127:9,10-Dimethyl-1,2-benzanthracene; C058216:perilla seed oil; D013024:Soybean Oil; D012450:Safflower Oil; D019813:1,2-Dimethylhydrazine